Anika Therapeutics, Inc.
ANIK
$9.72
-$0.04-0.41%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 83.47% | 88.08% | 93.54% | 94.43% | -175.08% |
| Total Depreciation and Amortization | -44.61% | -74.56% | -71.33% | -71.01% | -46.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -82.96% | -88.27% | -89.82% | -85.39% | 346.16% |
| Change in Net Operating Assets | 102.08% | 63.99% | 50.95% | -0.81% | -23.83% |
| Cash from Operations | -12.17% | -47.39% | 124.00% | 313.70% | 250.84% |
| Capital Expenditure | 12.38% | 44.93% | -6.52% | 3.98% | -15.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 93.24% | 91.23% | 39.33% | -29.48% | -44.98% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -68.25% | -68.25% | -45.02% | -41.18% | -29.14% |
| Repurchase of Common Stock | -43.19% | -38.90% | 10.41% | 45.88% | 46.03% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 25.04% | -193.46% | -50.92% | -16.62% | -17.24% |
| Foreign Exchange rate Adjustments | 184.36% | 294.42% | -744.44% | -422.78% | -171.21% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 110.03% | -97.69% | 9.53% | 22.00% | 51.63% |